Filing Analysis
Nature's Sunshine Products, Inc. announced the appointment of Ruth Perkins as Executive Vice President and Chief Financial Officer, effective September 1, 2026. The filing also includes the company's second quarter 2026 earnings release.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- Ruth Perkins appointed as EVP and CFO, effective September 1, 2026.
- Perkins joins from The Estée Lauder Companies Inc., where she was SVP, Global Value Chain Finance.
- Base salary is set at $575,000 with a target annual bonus of 70% of base salary.
- Total equity awards target approximately $1.65 million in RSUs and PSUs.
- Includes a one-time relocation payment of $150,000 (subject to clawback/vesting).
- Jon Lanoy will continue as Principal Accounting Officer.
Nature’s Sunshine Products, Inc. issued an 8-K to announce its financial results for the first quarter ended September 30, 2025. The filing serves as a formal notice of the earnings release and includes non-GAAP financial information.
📋 Key Facts
- Report date: November 6, 2025
- Reporting period: First quarter ended September 30, 2025
- The company issued a press release containing financial results (Exhibit 99.1)
- Management provided non-GAAP financial information and reconciliations in the press release.
Nature’s Sunshine Products, Inc. has announced the appointment of Kenneth Romanzi as new CEO and Board member, effective October 29, 2025. This follows a leadership transition process initiated in May 2025 following Terrence O. Moorehead's decision to step down.
🚩 Red Flags
- Significant severance package for outgoing CEO (18 months of base salary).
- Leadership transition occurring mid-year/post-May search period suggests ongoing organizational change.
📋 Key Facts
- Kenneth Romanzi appointed CEO and Board member, effective October 29, 2025.
- Romanzi brings 40+ years of CPG experience, including roles at B&G Foods, Nabisco, Hasbro, and Ocean Spray.
- New CEO compensation includes $850,000 annual base salary and up to $3,000,000 in total RSU awards (split between time-based and performance-contingent).
- Outgoing CEO Terrence O. Moorehead will officially resign on October 29, 2025.
- Moorehead's separation agreement includes 18 months of estimated base salary severance and a pro-rated 2025 bonus.
Nature’s Sunshine Products, Inc. issued an 8-K to announce its financial results for the first quarter ended June 30, 2025. The filing serves as a formal announcement of the earnings release and includes non-GAAP financial information.
📋 Key Facts
- Report date: July 31, 2025
- Reporting period: First Quarter ended June 30, 2025
- The company issued a press release (Exhibit 99.1) containing financial results.
- Management provided non-GAAP financial information with GAAP reconciliations included in the exhibit.
Nature's Sunshine Products entered into agreements to repurchase the interests of Fosun Industrial in two Chinese joint ventures (Hong Kong and Shanghai) following Fosun Pharma's sale of a significant stake that dropped their ownership below 5%. The total cash consideration for these repurchases is $7.0 million.
🚩 Red Flags
- The trigger event was a significant sale of common stock by a major strategic partner (Fosun Pharma), which may indicate their shifting interest in the company or its region.
📋 Key Facts
- Fosun Pharma sold 2,854,607 shares on June 27, 2025, causing its ownership to fall below the 5% threshold required by existing operating agreements.
- The Company will purchase Fosun Industrial's interest in Nature’s Sunshine Hong Kong Limited for $3.9 million cash.
- The Company will purchase Fosun Industrial's interest in Shanghai Nature’s Sunshine Health Products Co., Ltd. for $3.1 million cash.
- Upon completion, the Company will have 100% ownership of both joint ventures.
- Repurchases are subject to regulatory approvals from the PRC State Administration for Market Regulation and Ministry of Commerce.
Nature’s Sunshine Products, Inc. announced a secondary public offering of 2,854,607 shares by selling stockholder Fosun Pharma USA, Inc. at $12.00 per share. The company is simultaneously engaging in a concurrent share repurchase program of up to $15 million to offset the dilution from the offering.
🚩 Red Flags
- Significant dilution potential via secondary offering of ~2.85M shares (though proceeds go to seller, not company).
- Large-scale exit by a major stakeholder (Fosun Pharma USA, Inc.).
📋 Key Facts
- Secondary public offering of 2,854,607 shares by Selling Stockholder Fosun Pharma USA, Inc.
- Offering price set at $12.00 per share.
- The Company will receive no proceeds from the secondary offering.
- Concurrent share repurchase agreement allows the company to buy up to $15 million of the offered shares.
- Lock-up period: Directors, officers, and significant stockholders are prohibited from selling for 90 days from June 25, 2025.
- Expected closing date: On or about June 27, 2025.
Terrence O. Moorehead has notified the Board of his decision to step down as President, CEO, and a member of the Board of Directors. His departure is effective upon the appointment of a successor.
🚩 Red Flags
- Sudden departure of the top executive (CEO) and President simultaneously.
- Departure includes a seat on the Board of Directors, reducing leadership continuity.
📋 Key Facts
- Effective date: Upon appointment of a successor President and CEO.
- Roles departing: President, Chief Executive Officer, and Director.
- Notification date: May 28, 2025.
- Filing date: June 2, 2025.
Nature's Sunshine Products, Inc. announced its Q1 2025 financial results and reported the outcomes of its 2025 Annual Meeting of Shareholders held on April 30, 2025.
📋 Key Facts
- Company released Q1 2025 financial results via press release on May 6, 2025.
- Shareholders elected all eight nominees to the Board of Directors at the Annual Meeting.
- Shareholders approved an advisory resolution regarding executive officer compensation.
- Shareholders ratified the appointment of Deloitte & Touche LLP as independent registered public accountants for the fiscal year ending December 31, 2025.
Nature’s Sunshine Products, Inc. issued an 8-K to announce its financial results for the fourth quarter and full year ended December 31, 2024.
📋 Key Facts
- Report date: March 11, 2025
- Reporting period: Q4 and Full Year ended December 31, 2024
- The filing includes a press release (Exhibit 99.1) containing non-GAAP financial information.
- Management provided reconciliations of GAAP to non-GAAP results in the attached exhibit.
Natures Sunshine Products Inc. announced salary increases for two key executives: the Chief Financial Officer and the Executive Vice President of Global Supply Chain.
📋 Key Facts
- CFO L. Shane Jones' base salary increased from $460,000 to $478,400, effective March 4, 2025.
- EVP, Global Supply Chain Martin Gonzalez's base salary increased from $390,000 to $405,600, effective March 4, 2025.
- The increases were approved by the Company's Compensation Committee.
Natures Sunshine Products announced the appointment of Katie A. May to its Board of Directors and the notification that Richard D. Moss will not stand for re-election at the upcoming 2025 annual shareholder meeting.
🚩 Red Flags
- Departure of a director (Richard D. Moss), though explicitly noted as non-disagreement.
📋 Key Facts
- Katie A. May appointed to the Board of Directors on January 30, 2025; she will serve on the Compensation and Governance Committees.
- Ms. May is an independent director under NASDAQ standards with a background in scaling companies like Kidspot and ShippingEasy.
- Richard D. Moss notified the board on February 4, 2025, that he will not stand for re-election at the 2025 annual shareholder meeting.
- The company stated Mr. Moss's decision was not due to any disagreement with the company.
Nature's Sunshine Products, Inc. announced its second quarter financial results for the period ended September 30, 2024, and appointed Steven J. Fasching to its Board of Directors.
📋 Key Facts
- Company released Q2 financial results (ended Sept 30, 2024) via press release on November 7, 2024.
- Steven J. Fasching appointed to the Board of Directors effective November 6, 2024.
- Mr. Fasching will serve on the Compensation and Audit Committees.
- Mr. Fasching joins from Deckers Brands, where he has served as CFO since June 2018.
Nature’s Sunshine Products, Inc. issued an 8-K to announce its financial results for the second quarter ended June 30, 2024. The filing serves as a formal notification that a press release containing both GAAP and non-GAAP financial information has been released.
📋 Key Facts
- Report date: August 8, 2024
- Reporting period: Second Quarter ended June 30, 2024
- The company provided a press release (Exhibit 99.1) containing financial results
- Management included non-GAAP financial information in the announcement
Nature's Sunshine Products, Inc. announced its Q1 2024 financial results via press release and reported the outcomes of its 2024 Annual Meeting of Shareholders held on May 1, 2024.
📋 Key Facts
- The Company released Q1 2024 financial results on May 7, 2024 (Exhibit 99.1).
- Held the 2024 Annual Meeting of Shareholders on May 1, 2024.
- All eight nominated directors were elected to serve until the next Annual Meeting.
- Shareholders approved an advisory resolution regarding executive officer compensation.
- Shareholders ratified the appointment of Deloitte & Touche LLP as independent registered public accountants for the fiscal year ending December 31, 2024.
Nature's Sunshine Products, Inc. issued an 8-K to announce its financial results for the fourth quarter and full fiscal year ended December 31, 2023.
📋 Key Facts
- Financial results announced for the four quarter and full year ended December 31, 2023.
- The filing includes a press release (Exhibit 99.1) containing non-GAAP financial information.
- Report date: March 12, 2024.
The Company announced compensatory arrangement changes for three key executives, including base salary increases and adjustments to annual cash incentive targets. The changes are effective as of March 11, 2024.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- CEO Terrence O. Moorehead: Base salary increased from $800,000 to $832,000; target annual cash incentive increased from 100% to 105%.
- CFO L. Shane Jones: Base salary increased from $430,000 to $460,000; target annual cash incentive increased from 60% to 70%.
- EVP Global Supply Chain Martin Gonzalez: Base salary increased from $375,000 to $390,000.
- All compensation changes are effective March 11, 2024.
This is an amendment to a previous 8-K filing regarding the results of the company's 2023 annual meeting. The purpose of the amendment is to disclose the board's decision on the frequency of shareholder advisory votes on executive compensation.
📋 Key Facts
- The filing amends an original 8-K filed on May 9, 2023.
- Stockholders voted on the frequency of future advisory votes regarding named executive officer compensation at the Annual Meeting held on May 3, 2023.
- The highest number of votes was cast in favor of holding an advisory vote every year.
- The Board of Directors has decided to conduct an advisory vote on executive compensation annually.